Latest Asx News

OD6 Metals has raised $2.5 million through a strongly supported placement to fast-track rare earth testwork and copper drilling programs at its flagship Australian projects.

iTech Minerals has confirmed it will soon announce new high-grade antimony findings at its Reynold Range Project, following a notable uptick in its share price and trading volume.

Star Minerals Limited will have its trading suspension lifted on 19 August 2025 following the release of important assay results and its response to an ASX Price Query.

Star Minerals Limited addresses a sharp rise in its share price and trading volume, attributing the movement to pending assay results from recent drilling activities. The company confirms compliance with ASX disclosure rules while preparing to release interpreted data.

Star Minerals reports exceptional shallow gold assay results from infill drilling at its Tumblegum South Gold Project, reinforcing the deposit's quality and advancing plans for production. The company anticipates further assay results and an updated resource estimate soon.

Mammoth Minerals has finalized its acquisition of two promising US gold projects and revamped its leadership to spearhead a high-grade gold drilling campaign.

Alternative Investment Trust (AIQ) has announced a 1-for-1 non-renounceable rights issue at $1.47 per unit, aiming to raise capital for ongoing investments and increase annual distributions to 10% of adjusted net tangible assets starting early 2026.

Sun Silver Limited has confirmed significant high-grade silver, gold, and antimony mineralisation at surface through rock chip sampling at its Maverick Springs Project in Nevada, highlighting potential for early-stage revenue and resource expansion.

Kingston Resources is accelerating growth at its Mineral Hill mine with the largest exploration program in decades and fast-tracked underground mining set for late 2025, backed by proceeds from the Misima Gold Project sale.

Andromeda Metals has addressed recent share price gains and trading volume spikes, attributing the activity to ongoing funding efforts and strategic project studies rather than undisclosed information.

AdAlta Limited outlines its innovative 'East to West' cellular immunotherapy approach, in-licensing Asian CAR-T assets and progressing clinical trials in Australia to unlock value. The company also seeks partners for its anti-fibrotic and anti-malarial protein therapeutics.

SEEK Limited has released its FY2025 full year results presentation, offering insights into its financial and operational performance amid evolving market dynamics.